AHF Thanks HRSA for Standing Up Against Drug Industry Attack on 340B [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
Health Resources and Services Administration move against Sanofi's attack on the 340B Drug Pricing Program. In a letter to Sanofi HRSA Letter to Paul Hudson HRSA warned Sanofi that if it proceeds with converting 340B from a discount to a rebate program, it will no longer have access to the lucrative and highly profitably taxpayer-supported Medicare and Medicaid prescription drug markets. HRSA wrote " … this unapproved credit proposal violates Sanofi's obligations under the 340B statute…." "Sanofi joins Bristol Myers Squibb, Johnson & Johnson and Eli Lilly and Company in their latest attempt to strangle the 340B Drug Pricing Program that is the backbone of the country's healthcare safety net. The blatant actions of these four highly profitable drug industry giants reveals what we all know, that drug companies will never stop trying to kill 340B," said John Hassell , AHF's national director of advocacy. "AHF is grateful that HRSA is drawing a bright line in the sand on the industry's
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- 1 Beaten-Down Stock That Could Soar by 50% in 2025, According to Wall Street [Yahoo! Finance]Yahoo! Finance
- These CEO's reveal their top festive reads for the year [Fortune]Fortune
- Olympian Jordan Chiles is setting her sights on a new goal: raising awareness of type 1 diabetes [Fortune]Fortune
- Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III [Yahoo! Finance]Yahoo! Finance
- SK bioscience and Sanofi expand agreement for pneumococcal conjugate vaccines [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 12/23/24 - Form 6-K
- 12/20/24 - Form 6-K
- 12/13/24 - Form 6-K
- SNY's page on the SEC website